首页 | 本学科首页   官方微博 | 高级检索  
检索        

恶性肿瘤患者化疗及生物化学治疗后淋巴细胞亚群的变化
引用本文:高全立,宋永平,李玉富,魏旭东,汪萍.恶性肿瘤患者化疗及生物化学治疗后淋巴细胞亚群的变化[J].肿瘤基础与临床,2004,17(5):310-311.
作者姓名:高全立  宋永平  李玉富  魏旭东  汪萍
作者单位:河南省肿瘤医院血液科,河南,郑州,450008;河南省肿瘤医院血液科,河南,郑州,450008;河南省肿瘤医院血液科,河南,郑州,450008;河南省肿瘤医院血液科,河南,郑州,450008;河南省肿瘤医院血液科,河南,郑州,450008
摘    要:目的 观察恶性肿瘤患者化疗和生物化学治疗前后淋巴细胞亚群的变化及其临床意义。方法 利用流式细胞仪测定 3 2例化疗前后和 2 6例生物化学治疗前后的淋巴细胞亚群及其活性。结果 化疗结束后 1个月患者CD2 5 及NK细胞较化疗前明显降低 (P <0 0 5 ) ,CD4 和CD8 细胞无明显变化 (P >0 0 5 )。化疗后应用免疫治疗组CD2 5 及NK细胞较化疗前明显升高 (P <0 0 1及P <0 0 5 )。结论 化疗对恶性肿瘤患者细胞免疫功能有明显抑制作用 ,化疗结束后应用生物反应调节剂对恶性肿瘤患者的细胞免疫功能有明显改善作用。

关 键 词:肿瘤  化疗  生物化学治疗  细胞免疫
文章编号:1003-1464(2004)05-0310-02
修稿时间:2004年8月10日

Changes of Lymphocyte Subsets of Patients Suffered from Malignant Tumors After Treated with Chemotherapy and Biochemotherapy
Gao Quanli,Song Yongping,Li Yufu,Wei Xudong,Wang Ping.Changes of Lymphocyte Subsets of Patients Suffered from Malignant Tumors After Treated with Chemotherapy and Biochemotherapy[J].journal of basic and clinical oncology,2004,17(5):310-311.
Authors:Gao Quanli  Song Yongping  Li Yufu  Wei Xudong  Wang Ping
Abstract:Objective To study lymphocyte subsets changes in patients with malignant tumors after chemotherapy or biochemotherapy and their clinical significance.Methods Thirty-two cases were treated with chemotherapy and twenty-six cases were treated with biochemotherapy, and lymphocyte subsets were determined by flowcytometry.Results Chemotherapy significantly decreased CD25 and NK cells(P<0.05), while CD4 and CD8 cells changed little (P>05). Biochemoyherapy elevated CD25 and NK cells (P<0.01 and P<0.05), while CD4 and CD8 cells remained unchanged (P>05).Conclusions Chemotherapy suppresses the activity of cell immune, and treated with biological responses modifiers to patients with malignant tumors after chemotherapy can improve their cell immunological function.
Keywords:neoplasm  chemotherapy  biochemotherapy  cell immune
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号